Literature DB >> 29617531

Consanguineous Marriage and the Psychopathology of Progeny: A Population-wide Data Linkage Study.

Aideen Maguire1, Foteini Tseliou2, Dermot O'Reilly1.   

Abstract

Importance: Approximately 1 in 10 children worldwide are born to consanguineous parents. The literature on consanguinity and mental health of progeny is scarce despite the fact that many of the factors associated with consanguineous unions are also associated with mental health. Objective: To investigate if children of consanguineous parents are at increased risk of common mood disorders or psychoses. Design, Setting, and Participants: This investigation was a retrospective population-wide cohort study of all individuals born in Northern Ireland between January 1, 1971, and December 31, 1986, derived from the Child Health System data set and linked to nationwide administrative data sources on prescription medication and death records. Data from the Child Health System data set identified all 447 452 births delivered to mothers residing in Northern Ireland between 1971 and 1986. The final data set comprised 363 960 individuals, alive and residing in Northern Ireland in 2014, with full data on all variables. The dates of analysis were June 1 to October 31, 2017. Main Outcomes and Measures: Degree of parental consanguinity was assessed from questions asked of the parents during routine health visitor house calls within 2 weeks of the child's birth. Potential mental ill health was estimated by receipt of psychotropic medication in 2010 to 2014. Ever or never use was used for the main analysis, with sensitivity analyses using a cutoff of at least 3 months' prescriptions. Receipt of antidepressant or anxiolytic medications was used as a proxy for common mood disorders, whereas receipt of antipsychotic medications was used as a proxy indicator of psychoses.
Results: Of the 363 960 individuals (52.5% [191 102] male), 609 (0.2%) were born to consanguineous parents. After full adjustment for factors known to be associated with poor mental health, multilevel logistic regression models found that children of first-cousin consanguineous parents were more than 3 times as likely to be in receipt of antidepressant or anxiolytic medications (odds ratio, 3.01; 95% CI, 1.24-7.31) and more than twice as likely to be in receipt of antipsychotic medication (odds ratio, 2.13; 95% CI, 1.29-3.51) compared with children of nonrelated parents. Conclusions and Relevance: A child of consanguineous parents is at increased risk of common mood disorders and psychoses.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29617531      PMCID: PMC6145769          DOI: 10.1001/jamapsychiatry.2018.0133

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  50 in total

1.  Association between consanguineous marriages and risk of pre-eclampsia.

Authors:  Zahra Anvar; Bahia Namavar-Jahromi; Mostafa Saadat
Journal:  Arch Gynecol Obstet       Date:  2010-06-02       Impact factor: 2.344

2.  Adult functional outcome of those born small for gestational age: twenty-six-year follow-up of the 1970 British Birth Cohort.

Authors:  R S Strauss
Journal:  JAMA       Date:  2000-02-02       Impact factor: 56.272

3.  Non-linear relationship between an index of social deprivation, psychiatric admission prevalence and the incidence of psychosis.

Authors:  T J Croudace; R Kayne; P B Jones; G L Harrison
Journal:  Psychol Med       Date:  2000-01       Impact factor: 7.723

4.  An algorithm to identify antidepressant users with a diagnosis of depression from prescription data.

Authors:  Helga Gardarsdottir; Antoine C G Egberts; Liset van Dijk; Miriam C J M Sturkenboom; Eibert R Heerdink
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-01       Impact factor: 2.890

5.  Does consanguinity increase the risk of schizophrenia? Study based on primary health care centre visits.

Authors:  Abdulbari Bener; Elnour E Dafeeah; Nancy Samson
Journal:  Ment Health Fam Med       Date:  2012-12

6.  Paternal age at childbearing and offspring psychiatric and academic morbidity.

Authors:  Brian M D'Onofrio; Martin E Rickert; Emma Frans; Ralf Kuja-Halkola; Catarina Almqvist; Arvid Sjölander; Henrik Larsson; Paul Lichtenstein
Journal:  JAMA Psychiatry       Date:  2014-04       Impact factor: 21.596

7.  Gender differences in the incidence of definite schizophrenia and atypical psychosis--focus on negative symptoms of schizophrenia.

Authors:  N Ring; D Tantam; L Montague; D Newby; D Black; J Morris
Journal:  Acta Psychiatr Scand       Date:  1991-12       Impact factor: 6.392

8.  What do health visitors do? A national survey of activities and service organisation.

Authors:  S Cowley; W Caan; S Dowling; H Weir
Journal:  Public Health       Date:  2007-07-02       Impact factor: 2.427

9.  Residential segregation, dividing walls and mental health: a population-based record linkage study.

Authors:  Aideen Maguire; Declan French; Dermot O'Reilly
Journal:  J Epidemiol Community Health       Date:  2016-02-08       Impact factor: 3.710

10.  Biological insights from 108 schizophrenia-associated genetic loci.

Authors: 
Journal:  Nature       Date:  2014-07-22       Impact factor: 49.962

View more
  2 in total

1.  Age dependent association of inbreeding with risk for schizophrenia in Egypt.

Authors:  Lora McClain; Hader Mansour; Ibtihal Ibrahim; Lambertus Klei; Warda Fathi; Joel Wood; Chowdari Kodavali; Alina Maysterchuk; Shawn Wood; Farha El-Chennawi; Nahed Ibrahim; Ahmed Eissa; Wafaa El-Bahaei; Hanan El Sayed; Amal Yassein; Salwa Tobar; Hala El-Boraie; Eman El-Sheshtawy; Hala Salah; Ahmed Ali; Serkan Erdin; Bernie Devlin; Michael Talkowski; Vishwajit Nimgaonkar
Journal:  Schizophr Res       Date:  2020-01-09       Impact factor: 4.939

2.  Psychotic Experiences Are Associated With Paternal Age But Not With Delayed Fatherhood in a Large, Multinational, Community Sample.

Authors:  Franck Schürhoff; Baptiste Pignon; Mohamed Lajnef; Romain Denis; Bart Rutten; Craig Morgan; Robin M Murray; Marion Leboyer; Jim van Os; Andrei Szöke
Journal:  Schizophr Bull       Date:  2020-02-12       Impact factor: 7.348

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.